The global contrast media market was valued at USD 5,231.4 million in 2022, which is expected to reach USD 7,647.7 million by 2030, growing at a CAGR of 4.9% during 2022–2030.

1. © P&S Intelligence. All Rights Reserved 1
Contrast Media
Market

2. © P&S Intelligence. All Rights Reserved 2
In 2022, the contrast media market was worth around USD 5,231.4 million, and it is projected to
advance at a 4.9% CAGR from 2022 to 2030, hitting USD 7,647.7 million by 2030, according to P&S
Intelligence.
Diagnostic imaging procedures, such as ultrasound, X-ray, and pioneering modalities, including CT
and MRI are turning progressively common with the growing occurrence of intricate comorbidities
and chronic illnesses. Furthermore, such modalities are gradually improving and becoming more
exact to diagnose these circumstances, and contrast media is a main product that improves image
quality.
Request for sample pages of this report: https://www.psmarketresearch.com/market-
analysis/contrast-media-market/report-sample
The occurrence of chronic conditions has surged over the years because of the increasing deskbound
lifestyles of individuals. Furthermore, there has been a substantial intake of high-calorie foods and
insufficient physical activity, which are ultimately contributing to the growth of chronic diseases.
Key players in the market have a ton of opportunities because of surging R&D events in novel
contrast agents and the making of innovative applications for them.
For example, to change the frequently-used gadolinium-based imaging agents, Gang Han, PHD.,
professor of molecular pharmacology and biochemistry, has got seed capital from the UMass
Technology Development Fund to examine a safer, novel biogenic family of contrast agents for

3. © P&S Intelligence. All Rights Reserved 3
In 2022, based on modality, the X-ray/CT category held the largest contrast media market share, at approximately
50%. This can be ascribed to the growth in the frequency of communicable and non-communicable diseases in
the past few years. As per the study, there has been a noteworthy increase in the count of CT scans during the
COVID-19 pandemic.
In 2022, based on application, cardiovascular disorders held the largest market share, of around 40%, credited to
the increasing number of elder populations. According to a study conducted by the WHO, the major cause of
demise globally is cardiovascular diseases, which claim 17.9 million lives yearly. Additionally, the pace at which the
aging populace is increasing is significantly higher than in the past.
In 2022, according to the regional analysis, North America held the largest market share, at approximately 45%.
The count of inpatient check-ups in the continent is growing, credited to the deep-rooted healthcare amenities,
complete disease screening programs introduced by provincial, federal, and state governments, easy access to
leading-edge technology, and rising requirements for improved management of the present diseases.
Browse full report at: https://www.psmarketresearch.com/market-analysis/contrast-media-market
Additionally, the existence of the key players in the continent is a vital contributing factor to the market
development.
Hence, the contrast media industry is growing because of the increasing volume of diagnostic imaging tests for
all types of diseases, and is also projected to grow more in the future.

4. © P&S Intelligence. All Rights Reserved 4
Disclaimer:
P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data
provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies
or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. the information or analysis in P&S Intelligence
publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication,
but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications.
All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced
in any form without prior written agreement of their owners.
An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part
thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become
realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd.
psmarketresearch.com
To know more about us, visit our website
For queries related to sales, contact us at:
US/Canada Toll-Free: 1-888-778-7886
International: +1-347-960-6455
India: +91 120 4541 337
enquiry@psmarketresearch.com